Biotech

Startups

Biotech Startups Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 30.11.2023.

Wells Fargo
Biotechnology
United States
NASDAQ
Email
Finance

@Genetic Engineering & Biotechnology News shared
On Nov 27, 2023
Fake tweet - https://www.etfdailynews.com/2023/11/26/sutro-biopharma-inc-nasdaqstro-receives-14-00-average-target-price-from-analysts/
Open
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives $14.00 Average Target Price from Analysts

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives $14.00 Average Target Price from Analysts

Shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Get Free Report) have received a consensus rating of “Moderate Buy” from the eight ratings firms that are covering the firm, MarketBeat ...

@Genetic Engineering & Biotechnology News shared
On Nov 28, 2023
Fake tweet - https://www.etfdailynews.com/2023/11/27/sana-biotechnology-nasdaqsana-trading-down-4-8/
Open
Sana Biotechnology (NASDAQ:SANA) Trading Down 4.8%

Sana Biotechnology (NASDAQ:SANA) Trading Down 4.8%

Sana Biotechnology, Inc. (NASDAQ:SANA – Get Free Report)’s share price was down 4.8% during trading on Monday . The company traded as low as $4.15 and last traded at $4.17. Approximately ...

@Genetic Engineering & Biotechnology News shared
On Nov 26, 2023
Fake tweet - https://www.etfdailynews.com/2023/11/25/redhill-biopharma-nasdaqrdhl-research-coverage-started-at-stocknews-com/
Open
RedHill Biopharma (NASDAQ:RDHL) Research Coverage Started at StockNews.com

RedHill Biopharma (NASDAQ:RDHL) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of RedHill Biopharma (NASDAQ:RDHL – Free Report) in a research report sent to investors on Wednesday. The firm issued a hold rating on the ...

@Genetic Engineering & Biotechnology News shared
On Nov 28, 2023
Fake tweet - https://www.etfdailynews.com/2023/11/27/point-biopharma-global-sees-unusually-large-options-volume-nasdaqpnt/
Open
POINT Biopharma Global Sees Unusually Large Options Volume (NASDAQ:PNT)

POINT Biopharma Global Sees Unusually Large Options Volume (NASDAQ:PNT)

POINT Biopharma Global Inc. (NASDAQ:PNT – Get Free Report) saw unusually large options trading activity on Monday. Stock traders purchased 9,344 call options on the stock. This is an ...

@Genetic Engineering & Biotechnology News shared
On Nov 26, 2023
Fake tweet - https://www.etfdailynews.com/2023/11/25/can-fite-biopharma-nysecanf-coverage-initiated-at-stocknews-com/
Open
Can-Fite BioPharma (NYSE:CANF) Coverage Initiated at StockNews.com

Can-Fite BioPharma (NYSE:CANF) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a report published on Wednesday. The firm issued a hold rating on the stock. Separately, HC ...

@Genetic Engineering & Biotechnology News shared
On Nov 30, 2023
Fake tweet - https://www.etfdailynews.com/2023/11/29/head-to-head-contrast-elutia-nasdaqelut-vs-pharmacyte-biotech-otcmktspmcbd/
Open
Head to Head Contrast: Elutia (NASDAQ:ELUT) vs. PharmaCyte Biotech (OTCMKTS:PMCBD)

Head to Head Contrast: Elutia (NASDAQ:ELUT) vs. PharmaCyte Biotech (OTCMKTS:PMCBD)

Elutia (NASDAQ:ELUT – Get Free Report) and PharmaCyte Biotech (OTCMKTS:PMCBD – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two ...

@Genetic Engineering & Biotechnology News shared
On Nov 27, 2023
Fake tweet - https://www.etfdailynews.com/2023/11/26/portage-biotech-prtg-to-release-earnings-on-monday/
Open
Portage Biotech (PRTG) to Release Earnings on Monday

Portage Biotech (PRTG) to Release Earnings on Monday

Portage Biotech (NASDAQ:PRTG – Get Free Report) will release its earnings data on Monday, November 27th. Portage Biotech (NASDAQ:PRTG – Get Free Report) last announced its quarterly ...

@Genetic Engineering & Biotechnology News shared
On Nov 28, 2023
Fake tweet - https://www.etfdailynews.com/2023/11/27/direxion-daily-sp-biotech-bull-3x-shares-nysearcalabu-stock-price-down-5-9/
Open
Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) Stock Price Down 5.9%

Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) Stock Price Down 5.9%

Shares of Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Get Free Report) fell 5.9% on Monday . The stock traded as low as $3.34 and last traded at $3.37. 8,458,154 shares ...